Open Access

Anti‑inflammatory activity of 3,5,6,7,3',4'‑hexamethoxyflavone via repression of the NF‑κB and MAPK signaling pathways in LPS‑stimulated RAW264.7 cells

  • Authors:
    • Eun Suk Son
    • Jeong‑Woong Park
    • Se‑Hee Kim
    • Hye Ran Park
    • Woorijarang Han
    • O Chul Kwon
    • Jae Young Nam
    • Sung Hwan Jeong
    • Chang Soo Lee
  • View Affiliations

  • Published online on: June 18, 2020     https://doi.org/10.3892/mmr.2020.11252
  • Pages: 1985-1993
  • Copyright: © Son et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Citrus peel has been used as a Traditional medicine in Asia to treat coughs, asthma and bronchial disorders. Therefore, the anti‑inflammatory effects of 3,5,6,7,3',4'‑hexamethoxyflavone (quercetogetin, QUE) isolated from Citrus unshiu peel were investigated in lipopolysaccharide (LPS)‑induced RAW 264.7 macrophage cells. The results showed that QUE repressed the production of prostaglandin E2 and nitric oxide by suppressing LPS‑induced expression of cyclooxygenase‑2 and inducible nitric oxide synthase. It also suppressed the production of interleukin (IL)‑6, IL‑1β, and tumor necrosis factor‑α cytokines, and decreased the nuclear translocation of NF‑κB by interrupting the phosphorylation of NF‑κB inhibitor α in macrophage cells. Based on the finding that QUE inhibited the phosphorylation of ERK protein expression in LPS‑induced RAW264.7 cells, it was confirmed that inhibition of inflammatory responses by QUE was mediated via the ERK pathway. Therefore, this study suggests that QUE has strong anti‑inflammatory effects, making it a promising compound for use as a therapeutic agent in treating inflammatory lung diseases, such as emphysema.
View Figures
View References

Related Articles

Journal Cover

September-2020
Volume 22 Issue 3

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Son E, Park JW, Kim SH, Park H, Han W, Kwon O, Nam J, Jeong S and Lee C: Anti‑inflammatory activity of 3,5,6,7,3',4'‑hexamethoxyflavone via repression of the NF‑κB and MAPK signaling pathways in LPS‑stimulated RAW264.7 cells. Mol Med Rep 22: 1985-1993, 2020
APA
Son, E., Park, J., Kim, S., Park, H., Han, W., Kwon, O. ... Lee, C. (2020). Anti‑inflammatory activity of 3,5,6,7,3',4'‑hexamethoxyflavone via repression of the NF‑κB and MAPK signaling pathways in LPS‑stimulated RAW264.7 cells. Molecular Medicine Reports, 22, 1985-1993. https://doi.org/10.3892/mmr.2020.11252
MLA
Son, E., Park, J., Kim, S., Park, H., Han, W., Kwon, O., Nam, J., Jeong, S., Lee, C."Anti‑inflammatory activity of 3,5,6,7,3',4'‑hexamethoxyflavone via repression of the NF‑κB and MAPK signaling pathways in LPS‑stimulated RAW264.7 cells". Molecular Medicine Reports 22.3 (2020): 1985-1993.
Chicago
Son, E., Park, J., Kim, S., Park, H., Han, W., Kwon, O., Nam, J., Jeong, S., Lee, C."Anti‑inflammatory activity of 3,5,6,7,3',4'‑hexamethoxyflavone via repression of the NF‑κB and MAPK signaling pathways in LPS‑stimulated RAW264.7 cells". Molecular Medicine Reports 22, no. 3 (2020): 1985-1993. https://doi.org/10.3892/mmr.2020.11252